Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Azilsartan and S-Amlodipine in Healthy Volunteers
NCT06618079Phase 1Active, not recruiting
- Sponsor
- Huons
- Start
- Apr 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of azilsartan and Levamlodipine in hypertension (HTN) (2 cohorts), sponsored by Huons. Primary endpoints: Area Under the Curve over the dosing interval at steady state and Maximum plasma concentration at steady state. Started Apr 2024; status: active, not recruiting.
02
Drugs
azilsartanLevamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06618079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06618079.